CervoMed Inc.
CRVO
$2.89
-$0.02-0.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -97.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -97.30% | |||
| Cost of Revenue | -14.09% | -3.48% | |||
| Gross Profit | 13.96% | -1.81% | |||
| SG&A Expenses | 18.53% | 7.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.75% | -0.32% | |||
| Operating Income | 2.65% | -3.57% | |||
| Income Before Tax | 1.52% | -4.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.52% | -4.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.52% | -4.67% | |||
| EBIT | 2.65% | -3.57% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 1.56% | -4.63% | |||
| Normalized Basic EPS | 1.56% | -4.64% | |||
| EPS Diluted | 1.56% | -4.63% | |||
| Normalized Diluted EPS | 1.56% | -4.64% | |||
| Average Basic Shares Outstanding | 0.04% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.04% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||